PTAB Expunges Non-Compliant Motions for Observations on Cross-Examination
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by Damien Howard and Nathanael Luman, Ph.D.
The PTAB expunged non-compliant motions for observations on cross-examination in Xilinx, Inc. v. Papst Licensing GMBH & Co., KG, IPR2016-00104, Paper 22 & IPR2016-00105, Paper 22 (P.T.A.B. May 3, 2017).
Papst, the Patent Owner, filed a motion for observations on cross-examination testimony in two IPR proceedings brought by Petitioner Xilinx. The Petitioner opposed the motions and asserted that the observations should be disregarded because that they failed to follow the Office Patent Trial Practice Guide. The Guide states that observations should be in the following form:
In exhibit __, on page __, lines __, the witness testified __. This testimony is relevant to the __ on page __ of __. The testimony is relevant because __.
The PTAB found that the observations did not provide the substantive information required by the Guide for two reasons: (1) the Patent Owner did not provide citations to where the Patent Owner’s arguments were made in the record, and (2) the Patent Owner did not explain why the testimony was relevant. The PTAB therefore determined that the observations were not compliant with the Guide, constituted additional unauthorized briefing, and expunged the motions.
These decisions provide a reminder that practitioners should take care to closely follow the observation format provided in the Office Patent Trial Practice Guide to ensure all of the required citations and explanations are present and clearly identifiable by the PTAB.
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…